Yi Zhang - Dissemin

Papers authored by Yi Zhang

Distributing this paper is prohibited by the publisher

2024 Shanshan Suo, Dandan Zhao, Fenglin Li, Yi Zhang

, Sonia Rodriguez-Rodriguez

, Le Xuan Truong Truong Nguyen, Lucy Y. Ghoda, Nadia Carlesso

, Guido Marcucci, Bin Zhang, Jie Jin

Homoharringtonine Inhibits the NOTCH/MYC Pathway and Exhibits Anti-Tumor Effects in T-Cell Acute Lymphoblastic Leukemia

Upload

This paper was not found in any repository, but could be made available legally by the author.

Yi Zhang

, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang

, Wei Li, Qian Jiang

, Xiuli Wang, Jinwen Huang, Huanling Zhu

, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang and 12 other authors

Efficacy, safety, and survival findings after long‐term follow‐up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis

Upload

This paper is made freely available by the publisher.

2023 Qing Ling, Yutong Zhou, Yu Qian, Jiejing Qian, Yi Zhang

, Jinghan Wang, Yanan Zhu, Yile Zhou, Juying Wei, Chunmei Yang, Jie Sun, Wenjuan Yu, Jie Jin, Xiang Zhang

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML

Download from doi.org

Bin Zhang

, Dandan Zhao, Fang Chen, David Frankhouser

, Huafeng Wang, Khyatiben V. Pathak, Lei Dong, Anakaren Torres, Krystine Garcia-Mansfield, Yi Zhang

, Dinh Hoa Hoang, Min-Hsuan Chen, Shu Tao

, Hyejin Cho

, Yong Liang

and 18 other authors

Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis

Download from doi.org

Yi Zhang

, Hu Zhou, Minghui Duan

, Sujun Gao, Guangsheng He

, Hongmei Jing, Junmin Li, Liangming Ma, Huanling Zhu

, Chunkang Chang, Xin Du, Mei Hong

, Xin Li, Qingchi Liu, Wei Wang and 9 other authors

Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study

Upload

Yi Zhang

, Qike Zhang, Qingchi Liu, Huibing Dang, Sujun Gao, Wei Wang, Hu Zhou, Yuqing Chen, Liangming Ma, Jishi Wang, Haiping Yang, Binhua Lu, Hewen Yin, Liqing Wu, Shanshan Suo and 3 other authors

Safety and efficacy of jaktinib (a novelJAKinhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: Asingle‐arm,open‐label, phase 2, multicenter study

Upload

Xubo Gong, Yi Zhang

, Xin He, Milad Moloudizargari, Teng Yu, Lin Wang, Weiwei Liu, Lan Jin, Huiying Xu, Yang Xu, Zhihua Tao, Wenbin Qian

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting

Download from doi.org

Yao-Jia Shen, Yi Zhang

, Jie Chang, Hua-Feng Wang, Xing-Nong Ye, Li Zhu, Jie Jin, Hong-Hu Zhu

CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease

Upload

Huafeng Wang

, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma

, Yi Zhang

, Yile Zhou, Jiaying Wu, Xin Huang, Yungui Wang, Huan Xu, Hongyan Tong

and 2 other authors

Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis

Upload

2022 Yi Zhang

, Jiayan Gu, Ziyang Zhou, Xin Huang, Chenhui Bao, Jie Jin, Hongyan Tong

Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemia

Download from ashpublications.org

Yi Zhang

, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang

, Wei Li, Qian Jiang

, Xiuli Wang, Jinwen Huang, Huanling Zhu

, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang and 10 other authors

Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor‐naïve patients with myelofibrosis: Results of a phase II trial

Download from onlinelibrary.wiley.com

Li-Xia Zhu, Rong-Rong Chen, Lu-Lu Wang, Jia-Nai Sun, De Zhou, Li Li, Jie-Jing Qian, Yi Zhang

, Hong-Yan Tong, Wen-Juan Yu, Hai-Tao Meng, Wen-Yuan Mai, Wan-Zhuo Xie, Jie Jin, Xiu-Jin Ye and 1 other authors

A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia

Upload

Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang

, Jiejing Qian, Yungui Wang, Yongxian Hu

, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura

, Jie Jin

and 1 other authors

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia

Download from doi.org

Min Yang, Bide Zhao, Jinghan Wang, Yi Zhang

, Chao Hu, Lixia Liu, Jiayue Qin, Feng Lou, Shanbo Cao, Chengcheng Wang, Wenjuan Yu, Hongyan Tong, Haitao Meng, Jian Huang, Honghu Zhu and 1 other authors

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients

Download from doi.org

Yi Zhang

, Min Ji, Jin-Yan Zhao, Hua-Feng Wang, Chong-Wu Wang, Wei Li, Jing-Jing Ye, Fei Lu, Li-Hui Lin, Yan-Ting Gao, Jie Jin, Li Li, Chun-Yan Ji, Joan Ballesteros, Hong-Hu Zhu

Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy

Download from doi.org

2021 Yi Zhang

, Jie-Jing Qian, Yao-Jia Shen, Shu-Juan Hang, Jie Jin, Hong-Hu Zhu

The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

Upload

Xue-Ying Li, Yi-Le Zhou, Yi Zhang

, Xin Huang, Jian-Hu Li, Huan-Ping Wang, De Zhou, Li Li, Li-Xia Zhu, Mi-Xue Xie, Xian-Bo Huang, Wan-Zhuo Xie, Yin-Jun Lou, Hai-Tao Meng, Wen-Juan Yu and 4 other authors

Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemia

Upload